IRIS
DI STASI, SAVINO MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.668
EU - Europa 4.847
AS - Asia 4.184
SA - Sud America 811
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 12
Totale 62.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 52.556
SG - Singapore 2.152
IT - Italia 1.260
UA - Ucraina 807
CN - Cina 703
BR - Brasile 657
DE - Germania 644
FR - Francia 570
HK - Hong Kong 511
IE - Irlanda 484
RU - Federazione Russa 289
VN - Vietnam 246
KR - Corea 225
SE - Svezia 212
GB - Regno Unito 181
FI - Finlandia 177
PL - Polonia 80
ID - Indonesia 69
CA - Canada 58
JP - Giappone 58
AR - Argentina 55
IN - India 52
NL - Olanda 43
MX - Messico 37
CL - Cile 31
ES - Italia 24
BD - Bangladesh 22
IQ - Iraq 22
TR - Turchia 22
EC - Ecuador 20
ZA - Sudafrica 20
AT - Austria 19
PK - Pakistan 15
EU - Europa 13
VE - Venezuela 13
EG - Egitto 12
IL - Israele 12
PY - Paraguay 11
CO - Colombia 10
PH - Filippine 10
KG - Kirghizistan 9
AU - Australia 8
IR - Iran 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
CH - Svizzera 6
MA - Marocco 6
MY - Malesia 6
PE - Perù 6
BE - Belgio 5
DK - Danimarca 5
DZ - Algeria 5
GR - Grecia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
HN - Honduras 4
HU - Ungheria 4
JO - Giordania 4
KE - Kenya 4
RO - Romania 4
TW - Taiwan 4
KW - Kuwait 3
LT - Lituania 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
NR - Nauru 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SI - Slovenia 2
SM - San Marino 2
TH - Thailandia 2
TN - Tunisia 2
A1 - Anonimo 1
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GD - Grenada 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 62.585
Salva come PNG Salva come JPEG
Città #
Woodbridge 16.343
Wilmington 14.930
Houston 12.670
Fairfield 1.221
Singapore 1.081
Ann Arbor 730
Jacksonville 709
Ashburn 672
Hong Kong 505
Dublin 477
Seattle 477
Chandler 463
Cambridge 399
Medford 372
Beijing 337
Dearborn 239
Santa Clara 235
Lawrence 174
Rome 171
Dallas 114
Mülheim 113
Los Angeles 110
Buffalo 104
New York 94
Moscow 84
Milan 77
The Dalles 77
Menlo Park 76
Kraków 65
Ho Chi Minh City 63
San Diego 58
Jakarta 56
Phoenix 56
São Paulo 56
Dong Ket 53
University Park 50
Hanoi 49
Seongnam 41
Zhengzhou 41
Chicago 39
Boardman 36
London 36
Council Bluffs 35
Nuremberg 34
Falls Church 31
Helsinki 26
Munich 25
Redondo Beach 25
Guangzhou 22
Naples 22
Seoul 21
Rio de Janeiro 20
Tokyo 20
Bologna 19
Frankfurt am Main 19
Hefei 19
Montreal 19
Brooklyn 18
Curitiba 18
Nanjing 18
Norwalk 18
Redwood City 18
San Francisco 18
Verona 18
Columbus 17
Shanghai 17
Atlanta 16
Toronto 16
Temuco 15
Florence 14
Kunming 14
Stockholm 14
Belo Horizonte 13
San Jose 13
Jinan 12
Buenos Aires 11
Catania 11
Mountain View 11
Salvador 11
Turin 11
Warsaw 11
Amsterdam 10
Boston 10
Hangzhou 10
Orem 10
Campinas 9
Chennai 9
Groningen 9
Johannesburg 9
Kilburn 9
Saint Petersburg 9
Salt Lake City 9
Tampa 9
Brasília 8
Casoria 8
Elk Grove Village 8
Mexico City 8
Porto Alegre 8
Redmond 8
San Mateo 8
Totale 54.631
Salva come PNG Salva come JPEG
Nome #
Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm 764
L’ecocolor Doppler nella diagnosi di prostatite granulomatosa especifica: esperienza personale. 557
Cisti intraparenchimali del didimo: aspetti ecografici. 527
Updates in intravesical electromotive drug administration(A (R)) of mitomycin-C for non-muscle invasive bladder cancer 504
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 497
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo 487
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 486
New Frontiers in Intravesical Therapies and Drug Delivery 483
The Nocturnal alarm as a conditioning therapy in primary nocturnal enuresis. 481
Hexaminolevulinate hydrochloride in the detection of nonmuscle invasive cancer of the bladder 475
L'Ecografia nella diagnosi dei diverticoli dell'uretra femminile. 474
An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus calmette-guerin for non-muscle-invasive bladder cancer 471
Metastasis-free survival is a strong Surrogate of overall survival in localized prostate cancer 469
Concentration-depth profiles of mitomycin-C in the human bladder wall after passive diffusion, thermochemotherapy, and electromotive drug administration. 466
Prevalence of chronic prostatitis in men with premature ejaculation. 463
Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study 451
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. 442
La cistite emorragica da ciclofosfamide: nostra esperienza su 79 pazienti sottoposti a trapianto di midollo osseo. 439
Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. 438
Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens 438
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. 436
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 432
Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: A prospective randomized crossover study 431
Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. 431
Pelvic floor muscle behavior during Valsalva leak point pressure measurement in males and females affected by stress urinary incontinence. 430
Are referral centers for non-muscle-invasive bladder cancer compliant to EAU guidelines? A report from the vesical antiblastic therapy Italian study. 429
The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis. 428
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review. 427
Tissue pharmacokinetics of mitomycin-c in the human bladder wall after passive diffusion, thermo-chemotherapy and electromotive drug administration. 427
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass 426
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 426
Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. 425
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer 425
Electromotive delivery of mitomycin C into human bladder wall 424
Intravesical adjuvant electromotive drug administration (EMDA®) of mitomycin-C in patients with intermediate-risk non-muscle invasive bladder cancer: A randomized controlled trial 423
Electromotive administration of oxybutynin into the human bladder wall. 420
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. 419
Alfa-2a-interferon in neoadjuvant and adjuvant therapy of superficial ladder cancer: preliminary results. 417
The efficacy and safety of duloxetine in a multidrug regimen for chronic prostatitis/chronic pelvic pain syndrome. 416
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction. 415
Quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: a controlled prospective study. 415
Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells. 415
Single preoperative intravesical instillation of electromotive mitomycin-c for primary non-muscle invasive bladder cancer: a prospective randomized trial. 415
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys 414
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: A randomised controlled trial 413
Ontogenetic profile and thyroid hormone regulation of type-1 and type-8 glucose transporters in rat Sertoli cells. 413
Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies 412
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients 410
La terapia intralesionale dei tumori superficiali a cellule transizionali della vescica con interferone alfa ricombinante 408
The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin 408
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study. 407
Electromotive delivery of mitomycin C into human bladder wall 406
Single immediate preoperative intravesical instillation of electromotive mitomycin-C for low risk superficial bladder cancer: A prospective randomized study. 406
Diverticoli uretrali ed ascessi parauretrali nella donna: nostra esperienza. 400
Extraction and determination of oxybutynin in human bladder samples by reversed-phase high-performance liquid chromatography. 400
Intravesical sequential BCG and electromotive mitomycin versus BCG alone for stage pT1 urothelial bladder cancer 400
Intravesical electro-osmotic administration of mitomycin C 397
Successful management of retroperitoneal malignant fibrous histiocytoma involving both kidneys. 396
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study 395
Adjuvant alpha-interferon in renal cell carcinoma at high risk of relapse. A multicentre pilot study. 395
Intravesical sequential BCG and electromotive mitomycin versus BCG alone in high risk non-muscle invasive bladder cancer 395
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 392
Tumori vescicali intradiverticolari. Diagnosi preoperatoria. 391
Intravesical electromotive drug administration. 391
Our experience with Epirubicin in the treatmnet of superficial bladder tumors after conservative therapy. 390
Intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer 389
Percutaneous sequential bacillus Calmette-Guérin and mitomycin C for panurothelial carcinomatosis. 389
Lower urinary tract dysfunction and disability status in patients with multiple sclerosis 388
BCG nel carcinoma vescicale 388
Prognostic Factors And Risk Groups In T1g3 Patients Initially Treated With Bcg: Results Of A Multicenter Retrospective Series In 2530 Patients 388
Autonomic dysreflexia during urodynamics 387
Contemporary management of non-muscle invasive bladder cancer at italian referral centres adopting eau guidelines 387
The human bladder urothelium: new concepts and future perspectives. 386
Intravesical sequential bacillus Calmette-Guérin and electromotive mitomycin versus bacillus Calmette-Guérin alone for stage pt1 urothelial bladder cancer 386
Urodynamic assessment of bladder and urethral sphincter function before radical prostatectomy and during long-term follow-up. 385
Celecoxib for the prevention of nonmuscle invasive bladder cancer: Results from a matched control study 385
Intravesical electromotive administration of oxybutynin: from laboratoty to clinica field. 384
Malattia di La Peyronie. 383
Gender identity rather than sexual orientation impacts on facial preferences. 383
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction 381
The bladder urothelium: passive permeabilità and intravesical drug passive diffusion. 381
Color Doppler echography in the diagnosis of nonspecific granulomatous prostatis: personal experience. 378
Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients. 375
Extracorporeal piezoelectric lithotripsy: experience in 930 patients. 374
Transdermal electromotive administration of verapamil and dexametasone for Peyronie’s disease 374
Single preoperative intravesical instillation of electromotive anitomycin-C for primary non-muscle-invasive bladder cancer: A prospective randonsied trial 374
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis 373
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. 371
Long-term followup analysis of a randomized prospective study comparing intravesical electromotive mitomycin-C, passive diffusion mitomycin-C and bacillus Calmette-Guerin in patients with carcinoma in situ of the bladder. 370
Valsalva leak point pressure 369
Percutaneous sequential bacillus Calmette-Guèrin and mitomycin C for panurothelial carcinomatosis. 368
Cavernous hemangioma of the renal hilum presenting as an avascularized solid mass. 368
Defibrotide versus eparina calcica nella profilassi della trombosi venosa profonda in chirurgia urologica: studio randomizzato. 367
Il drenaggio percutaneo ecoguidato transperineale delle raccolte pelviche 366
Intravesical Sequential BCG and Elecromotive Mitomycin-C versus BCG Alone for Stage pT1 Urothelial Bladder Cancer. 366
Intralesional recombinant alpha 2a interferon therapy in superficial transitional cell carcinoma of the bladder 364
Urodynamics in spinal cord injured patients walking with reciprocating gait orthosis. 362
La scansione perineale nello studio della patologia prostatica ed uretrale. 359
Neoplasia prostatica: rapporto tra evoluzione locale e sistemica. 359
Il ruolo dell'ecografia nello studio delle neoplasie della via escretrice superiore 359
Totale 41.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 126.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.636 0 0 0 0 0 952 1.108 760 213 138 346 119
2021/20221.634 50 247 86 120 62 91 86 76 93 122 78 523
2022/20231.715 211 104 47 155 123 426 172 96 113 40 175 53
2023/2024782 70 41 83 47 51 93 90 46 43 45 22 151
2024/20254.080 163 993 454 191 80 346 207 132 258 313 506 437
2025/20262.706 503 261 837 404 535 166 0 0 0 0 0 0
Totale 62.960